As if the market reaction to the war in Ukraine were not enough, global stock markets have been smashed in an apparent in a hissy fit at rising US inflation and the possibility of sharply higher interest rates. Action today on the ASX was reminiscent of the market meltdown that Read more…
The ASX reacted with surprise to the historic news that IDT Australia has become the first company to produce an mRNA vaccine in Australia. The shares closed the day, up 40%. Less surprised were long term shareholders who have been awaiting this development for several months. Australia now joins Read more…
IDT Australia – July update IDT are not terribly forthcoming with regular updates to markets but we can begin to piece together various sources to picture what the near future may look like. The submissions deadline for the Australian governments approach-to-market (ATM) to onshore mRNA manufacturing passed on July Read more…
A few weeks back IDT Australia announced that the Australian government had approached the company to conduct a feasibility study into the possibility of producing a COVID-19 vaccine product at it’s Melbourne facility. Though IDT is yet to publicly update the market, it appears the company has completed the study Read more…
IDT Australia – Showing signs of life? After well over a decade in the wilderness, IDT Australia may just be beginning to show signs of life. The GFC sent a wrecking ball through IDT’s business at around the same time that company management failed to see the shifting Read more…